Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1

Science

Volumn 281, Issue 5385, 1998, Pages 2042-2045

  Le Good, J Ann ^a   Ziegler, Wolfgang H ^a   Parekh, Davey B ^a   Alessi, Dario R ^b   Cohen, Philip ^b   Parker, Peter J ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME ACTIVATOR; PHOSPHATIDYLINOSITIDE; PROTEIN KINASE; PROTEIN KINASE C;

ARTICLE; COMPLEX FORMATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME MECHANISM; HUMAN; HUMAN CELL; KIDNEY CELL; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN BINDING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; BINDING SITES; CELL LINE; CHROMONES; ENZYME ACTIVATION; ENZYME INHIBITORS; HUMANS; ISOENZYMES; MORPHOLINES; PHOSPHATIDYLCHOLINES; PHOSPHATIDYLINOSITOL PHOSPHATES; PHOSPHATIDYLSERINES; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN-SERINE-THREONINE KINASES; RECOMBINANT PROTEINS; TETRADECANOYLPHORBOL ACETATE;

EID: 0032566691     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.281.5385.2042     Document Type: Article

References (27)

1. J. W. Orr and A. C. Newton, J. Biol. Chem. 269, 27715 (1994).
2. S. Cazaubon, F. Bornancin, P. J. Parker, Biochem. J. 301, 443 (1994).
3. H. Hug and T. F. Sarre, ibid. 291, 329 (1993).
4. W. H. Ziegler et al., in preparation.
5. J. A. Le Good et al., data not shown.
6. N. T. Goode and P. J. Parker, FEBS Lett. 340, 145 (1994).
7. A. R. Olivier and P. J. Parker, Eur. J. Biochem. 200, 805 (1991).
8. J. A. Le Good, W. H. Ziegler, P. J. Parker, unpublished results.
9. K. Akimoto et al., EMBO J. 15, 788 (1996).
10. S. Moriya et al., Proc. Natl. Acad. Sci. U.S.A. 93, 151 (1996).
11. A. J. Flint, R. D. Paladini, D. E. Koshland Jr., Science 249, 408 (1990).
12. P. Garcia-Paramio, Y. Cabrerizo, F. Bornancin, P. J. Parker, Biochem. J. 333, 631 (1998).
13. D. H. Whelan and P. J. Parker, Oncogens, in press.
14. L. Stephens et al., Science 279, 710 (1998).
15. L. Stempka et al., J. Biol. Chem. 272, 6805 (1997).
16. D. R. Alessi et al., Curr. Biol. 7, 776 (1997).
17. D. R. Alessi, M. T. Kozlowski, Q. P. Weng, N. Morrice, J. Avruch, ibid. 8, 69 (1998).
18. N. Pullen et al., Science 279, 707 (1998).
19. A. R. Olivier and P. J. Parker, J. Biol. Chem. 269, 2758 (1994).
20. Phosphorylation site-specific antisera were generated with oligopeptides seven residues long encompassing the phosphoamino acid at residue 4. The peptides were coupled to keyhole limpet hemocyanin and used to immunize rabbits. Sera were characterized for specificity with dephospho- and phospho- forms of the peptide antigen. Protein immunoblotting analysis was carried out in the presence of dephosphopeptide (1 μg/ml) to suppress immunodetection of the dephosphorylated proteins.
21. S. Stabel, D. Schaap, P. J. Parker, Methods Enzymol. 200, 670 (1991).
22. D. R. Alessi et al., Curr. Biol. 7, 261 (1997).
23. T. Maniatis, J. Sambrook, E. F. Fritsch, Molecular Cloning, a Laboratory Manual (Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1989).
24. G. Hansra, F. Bornancin, R. Whelan, B. A. Hemmings, P. J. Parker, J. Biol. Chem. 271, 32785 (1996).
25. Lysis buffer: 1% (v/v) Triton X-100, 20 mM tris-HCl (pH 7.5), leupeptin (50 μg/ml), aprotinin (50 μg/ml), 1 mM dithiothreitol, and 0.1 mM phenylmethylsulfonyl fluoride.
26. U. K. Laemmli, Nature 227, 680 (1970).
27. We thank R. Marais (ICR, London) for providing the myc-pEFlink vector. We are grateful to the Deutsche Forschungsgemeinschaft (W.H.Z.), to the Medical Research Council (P.C. and D.R.A.), and to The Royal Society (P.C.) for support of this work.